CRTH2 modulating chimeric IgG1 antibodies (North Coast Biologics)

N/A

Report date: 2025/03/19 09:00:48

Base Information

Drug NameCRTH2 modulating chimeric IgG1 antibodies (North Coast Biologics)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionProstaglandin D2 receptor 2 modulators

TargetsProstaglandin D2 receptor 2

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNorth Coast Biologics LLC

China Registration ClassN/A

Develop Information

Active CompaniesNorth Coast Biologics LLC

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A